PTGS2 and neoplasm: It has also been reported that the COX‐2/PGE2 axis induces immunosuppressive functions in myeloid cells, and COX‐2/PGE2 blockade could reverse the immunosuppression, activate anti‐tumour immunity, and ultimately cause tumour regression.51, 52